Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats
Ivermectin is a widely used antiparasitic drug with known efcacy against several single-strain RNA viruses. Recent data shows signifcant reduction of SARS-CoV-2 replication in vitro by ivermectin concentrations not achievable with safe doses orally. Inhaled therapy has been used with success for...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | info:eu-repo/semantics/article |
| Language: | eng |
| Published: |
2023
|
| Online Access: | https://hdl.handle.net/10171/67181 |
Search Result 1
by Chaccour, C.J. (Carlos J.), Abizanda-Sarasa, G. (Gloria), Irigoyen-Barrio, A. (Angel), Casellas, A. (Aina), Aldaz, A. (Azucena), Martinez-Galan, F. (Fernando), Hammann, F. (Felix), Gil, A.G. (Ana Gloria)
Published 2024
Get full text
Published 2024
info:eu-repo/semantics/article